If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Henry O. Gosebruch net worth and biography

Henry Gosebruch Biography and Net Worth

EVP of AbbVie

Henry Gosebruch is Executive Vice President, Chief Strategy Officer at AbbVie, responsible for corporate strategy, business development and acquisitions, search and evaluation, alliance management and AbbVie Ventures.

Since joining AbbVie in December 2015, Mr. Gosebruch and his team have completed more than 75 partnering, collaboration, mergers & acquisitions (M&A) and venture transactions to bolster AbbVie’s commercial franchises and pipeline of innovative preclinical and clinical development programs, working closely with AbbVie colleagues globally.

Prior to joining AbbVie, Mr. Gosebruch was Co-Head of J.P. Morgan’s North American M&A Group based in New York. He worked on numerous complex M&A transactions involving companies in more than 20 countries.

Mr. Gosebruch serves on the board of Aptinyx. He is also member of the Advisory Board for the Life Sciences & Management Program at the University of Pennsylvania. At AbbVie, he is the executive chair of the Asian Leadership Network Employee Resource Group.

What is Henry O. Gosebruch's net worth?: The estimated net worth of Henry O. Gosebruch is at least $2.63 million as of May 16th, 2022. Mr. Gosebruch owns 16,623 shares of AbbVie stock worth more than $2,626,766 as of March 26th. This net worth evaluation does not reflect any other assets that Mr. Gosebruch may own. Learn More about Henry O. Gosebruch's net worth.
How do I contact Henry O. Gosebruch?: The corporate mailing address for Mr. Gosebruch and other AbbVie executives is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. AbbVie can also be reached via phone at (847) 932-7900. Learn More on Henry O. Gosebruch's contact information.
Has Henry O. Gosebruch been buying or selling shares of AbbVie?: Henry O. Gosebruch has not been actively trading shares of AbbVie during the past quarter. Most recently, Henry O. Gosebruch sold 83,960 shares of the business's stock in a transaction on Monday, May 16th. The shares were sold at an average price of $155.00, for a transaction totalling $13,013,800.00. Following the completion of the sale, the executive vice president now directly owns 16,623 shares of the company's stock, valued at $2,576,565. Learn More on Henry O. Gosebruch's trading history.
Who are AbbVie's active insiders?: AbbVie's insider roster includes Carlos Alban (Vice Chairman), Roxanne Austin (Director), Nicholas Donoghoe (SVP), Brian Durkin (VP), Richard Gonzalez (CEO), Henry Gosebruch (EVP), Robert Michael (Vice Chairman), Scott Reents (Sr. VP & CFO ), Timothy Richmond (EVP), Azita Saleki-Gerhardt (EVP), Laura Schumacher (Vice Chairman), Michael Severino (Vice Chairman), Elaine Sorg (SVP), Jeffrey Stewart (EVP), and Carrie Strom (SVP). Learn More on AbbVie's active insiders.
Are insiders buying or selling shares of AbbVie?: During the last year, insiders at the sold shares 13 times. They sold a total of 665,877 shares worth more than $101,802,173.50. The most recent insider tranaction occured on March, 13th when EVP Jeffrey Ryan Stewart sold 53,125 shares worth more than $8,089,875.00. Insiders at AbbVie own 0.1% of the company. Learn More about insider trades at AbbVie.
Information on this page was last updated on 3/13/2023.

Henry O. Gosebruch Insider Trading History at AbbVie

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2022	Sell	83,960	$155.00	$13,013,800.00	16,623
3/1/2022	Sell	15,000	$148.26	$2,223,900.00
7/29/2019	Buy	30,000	$67.28	$2,018,400.00	75,763
11/29/2018	Sell	42,450	$90.10	$3,824,745.00	30,350
10/30/2017	Sell	18,300	$90.55	$1,657,065.00	81,287
7/31/2017	Sell	18,000	$70.09	$1,261,620.00	96,074

Henry O. Gosebruch Buying and Selling Activity at AbbVie

AbbVie Company Overview

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Today's Range

Now: $158.02

$154.59

$158.48

50 Day Range

MA: $151.04

$144.61

$158.02

2 Week Range

Now: $158.02

$134.09

$175.91

Volume

4,678,822 shs

Average Volume

7,467,481 shs

Market Capitalization

$278.77 billion

P/E Ratio

23.91

Dividend Yield

3.81%

Beta

0.62

The Safest Option in Trades!

From Tradewins | Ad

Click here now!